3-Bromomethylphenidate

3-Bromomethylphenidate

3-Bromomethylphenidate (3-BrMP) is a psychoactive drug and research chemical that belongs to the phenidate class of compounds. It is a derivative of methylphenidate, a medication primarily used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.

Chemistry

3-Bromomethylphenidate is a halogenated derivative of methylphenidate. Its chemical structure includes a phenyl ring with a bromomethyl group at the 3-position, hence the name 3-Bromomethylphenidate. The presence of the bromine atom in the molecule can significantly alter the drug's pharmacological properties.

Pharmacology

The exact mechanism of action of 3-Bromomethylphenidate is not fully understood. However, it is believed to function similarly to other phenidate compounds, which work by inhibiting the dopamine transporter and norepinephrine transporter. This results in increased levels of dopamine and norepinephrine in the brain, which can lead to increased alertness, focus, and energy.

Effects

As a research chemical, the effects of 3-Bromomethylphenidate in humans are not well-documented. However, based on its chemical structure and similarity to other phenidate compounds, it is speculated that it may have stimulant effects. These could potentially include increased alertness, focus, and energy, as well as potential side effects such as increased heart rate, blood pressure, and potential for addiction.

Legal Status

The legal status of 3-Bromomethylphenidate varies by country. As a research chemical, it is not approved for medical use in many jurisdictions. In some countries, it may be classified as a controlled substance, making its possession, sale, or use illegal without a license or prescription.

See Also

• Methylphenidate
• Halogenated amphetamine
• Research chemical
• Psychoactive drug

‎